Jane Street’s Lisata Therapeutics LSTA Stock Holding History

Jane Street’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,220	Closed	-$22K	–	10515
2021 Q3	$22K	Hold	1,220	–	–	﹤0.01%	9735
2021 Q2	$29K	Sell	1,220 -27	-2%	-$640	﹤0.01%	9602
2021 Q1	$36K	Buy	+1,247	New	+$37.8K	﹤0.01%	8893

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street's LSTA Position: Q3 2022 in Review

Jane Street sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 1,144 shares — an estimated $9K sold.

Jane Street first reported a position in LSTA in Q1 2014 and held it in 6 quarters. The position peaked at $560K in Q2 2014. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

Jane Street reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
Jane Street sold 1,144 Lisata Therapeutics shares in Q3 2022, an estimated $9K.
Jane Street first reported a position in Lisata Therapeutics in Q1 2014 and held it in 6 quarters.
Jane Street's Lisata Therapeutics position peaked at $560K in Q2 2014.
22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on Jane Street's 13F filing for Q3 2022, filed 15 Nov 2022.